Vaccines and Diagnostics , said in a statement that the agreement would allow the company to combine its vaccines research and development strategy and pipeline with Tianyuan's knowledge of the fast growing Chinese market. The pharmaceutical giant rates...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Novartis acquires Chinese vaccine maker Zhejiang
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account